Tafamidis Meglumine (In House)

Tafamidis Meglumine is a selective transthyretin (TTR) stabilizer used for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). It works by stabilizing the transthyretin protein and preventing its dissociation into amyloid-forming fragments, thereby slowing disease progression and helping preserve cardiac function. It is an important therapy for patients with hereditary or wild-type ATTR cardiomyopathy.